Gilead Sciences (GILD)

EBITDA

$1.33B

TTM · Period ending: · USD

GILD logo

GILD EBITDA

Latest reported$1.33B
GILD TTM EBITDA (-$4.00M → $1.33B)
High-resolution chart · PNG

GILD ebitda history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Gilead Sciences EBITDA — Trailing twelve months (TTM) (USD)
Period endingEBITDA (USD)
1,334,000,000
14,017,000,000
13,582,000,000
13,671,000,000
10,972,000,000
10,582,000,000
4,435,000,000
3,919,000,000
5,269,000,000
4,784,000,000
10,496,000,000
10,688,000,000
10,640,000,000
10,411,000,000
8,852,000,000
7,599,000,000
8,624,000,000
8,946,000,000
11,329,000,000
12,305,000,000
9,510,000,000
4,534,000,000
4,133,000,000
4,119,000,000
1,799,000,000
7,189,000,000
7,559,000,000
6,696,000,000
10,886,000,000
10,588,000,000
10,305,000,000
11,494,000,000
12,467,000,000
14,441,000,000
15,933,000,000
17,590,000,000
18,148,000,000
18,376,000,000
19,219,000,000
20,687,000,000
21,785,000,000
22,799,000,000
23,445,000,000
22,135,347,000
19,963,347,000
18,713,347,000
16,318,347,000
12,996,892,000
10,476,772,000
7,029,556,000
4,859,817,000
4,727,925,000
4,616,450,000
4,515,095,000
4,251,102,000
4,036,368,000
4,016,048,000
3,994,207,000
4,158,654,000
4,109,050,000
4,081,684,000
4,047,809,000
4,287,986,000
4,511,171,000
4,412,926,000
4,169,832,000
3,784,562,000
3,438,806,000
3,175,683,000
3,006,089,000
2,874,848,000
2,603,707,000
2,463,918,000
2,364,352,000
2,215,786,000
2,188,827,000
2,051,057,000
1,871,503,000
1,682,583,000
1,559,494,000
1,394,284,000
1,300,312,000
1,147,031,000
944,856,000
855,162,000
735,438,000
656,097,000
578,504,000
492,941,000
441,455,000
350,783,000
293,377,000
248,717,000
158,621,000
95,435,000
37,628,000
-34,312,000
-87,226,000
-105,998,000
-100,249,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.